Study on caudal dexmedetomidine and intravenous dexmedetomidine in children for reducing pain after surgery
- Conditions
- Medical and Surgical,
- Registration Number
- CTRI/2022/02/040166
- Lead Sponsor
- Department of Anaesthesia and intensive care VMMC and Safdarjung Hospital
- Brief Summary
This study is randomized participant blinded parallel group study comparing two groups of 48 children each undergoing elective surgeries. One group is given caudal bupivacaine and caudal dexmedetomidine and other group is given caudal bupivacaine and intravenous dexmedetomidine .The study will be conducted in VMMC and Safdarjung Hospital,New Delhi . The primary objective of the study is post operative analgesia in children undergoing elective surgeries using FLACC scale and secondary objective of the study is intraoperative haemodynamic effects and sedation with dexmedetomidine given through caudal or intravenous route.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 96
- American society of Anaesthesiologists physical status I-II Age 1 to 8 year old children.
- Scheduled for elective surgery.
- Infection at the site of block.
- Coagulopathy.
- Pre-existing neurological or spinal disease and abnormalities of the sacrum.
- Allergy to local anaesthetics.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare caudal and intravenous dexmedetomidine for prolongation of post operative analgesia in children undergoing elective surgeries using FLACC scale Measuring post operative analgesia using FLACC score and Ramsay sedation score at 1 2 4 8 12 24hrs after surgery
- Secondary Outcome Measures
Name Time Method To compare the intra operative haemodynamic effects and sedation with dexmedetomidine given through caudal or intravenous route Monitoring baseline HR BP SPO2 preoperatively
Trial Locations
- Locations (1)
VMMC and Safdarjung Hospital
🇮🇳South, DELHI, India
VMMC and Safdarjung Hospital🇮🇳South, DELHI, IndiaKuldeep SinghPrincipal investigator8368510372cariappan.tiger.10@gmail.com